ESR1 and breast carcinoma: Observed changes in pathways related to collagen organization and turnover, anchoring fibril formation, and syndecan, integrin and non-integrin ECM interactions (Supplementary Data S6) might also be instrumental to demonstrate the anti-invasive effect of COMT on ER + breast cancer cells.